Trial intelligence / Profile preview

Octreotide added to pantoprazole for non-variceal gastrointestinal bleeding in children

IRCT20120415009475N6Phase 2Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Mar 2019
Modality
Peptides
Countries
1
01

Overview

Phase 2, randomised trial in gastrointestinal bleeding comparing Pantoprazole + octreotide with Pantoprazole + placebo (2 arms). Primary endpoints: Hemoglobin range during treatment, Need for blood transfusion and 1 more. Started Mar 2019; status: completed.

02

Drugs

octreotide
03

Conditions

gastrointestinal bleeding

Beyond the preview

Go deeper on IRCT20120415009475N6.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120415009475N6.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call